Insights

Diverse Product Portfolio NIZHPHARM offers a broad range of pharmaceuticals across over 17 therapeutic areas with a strong focus on cardiology, endocrinology, neurology, and reproductive health. This extensive variety provides multiple cross-sell and upsell opportunities within the healthcare sector.

Local Manufacturing Advantage With two production sites in Nizhny Novgorod and Obninsk, NIZHPHARM emphasizes localized manufacturing, which enables faster response times and tailored solutions for Russian healthcare providers, creating prospects for regional partnerships and customized product offerings.

Socially Significant Drugs The company’s portfolio includes 60 percent locally produced original socially significant medications, positioning it as a trusted partner for government and public health initiatives that may require subsidized or long-term supply agreements.

Digital Engagement Tools Utilizing a tech stack that includes Yandex Metrica and Facebook Pixel, NIZHPHARM actively tracks customer engagement and digital marketing effectiveness, providing opportunities to enhance online outreach and digital sales channels.

Market Position & Revenue As a leading Russian pharmaceutical manufacturer with an estimated revenue of around 10 billion dollars and over 2,200 employees, NIZHPHARM presents a significant growth partner for global and regional suppliers aiming to expand within the Russian healthcare market.

NIZHPHARM Group Tech Stack

NIZHPHARM Group uses 5 technology products and services including Facebook Pixel, AngularJS, Modernizr, and more. Explore NIZHPHARM Group's tech stack below.

  • Facebook Pixel
    Analytics
  • AngularJS
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Yandex Metrica
    Web Analytics
  • Facebook
    Widgets

Media & News

NIZHPHARM Group's Email Address Formats

NIZHPHARM Group uses at least 1 format(s):
NIZHPHARM Group Email FormatsExamplePercentage
First.Last@stada.ruJohn.Doe@stada.ru
49%
FirstLast@stada.ruJohnDoe@stada.ru
1%
First.Last@stada.ruJohn.Doe@stada.ru
49%
FirstLast@stada.ruJohnDoe@stada.ru
1%

Frequently Asked Questions

What is NIZHPHARM Group's official website and social media links?

Minus sign iconPlus sign icon
NIZHPHARM Group's official website is stada.ru and has social profiles on LinkedIn.

What is NIZHPHARM Group's SIC code NAICS code?

Minus sign iconPlus sign icon
NIZHPHARM Group's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NIZHPHARM Group have currently?

Minus sign iconPlus sign icon
As of December 2025, NIZHPHARM Group has approximately 1K employees across 3 continents, including AsiaEuropeNorth America. Key team members include Ceo: O. P.Coo: M. B.Chief Information Systems Specialist: В. Е.. Explore NIZHPHARM Group's employee directory with LeadIQ.

What industry does NIZHPHARM Group belong to?

Minus sign iconPlus sign icon
NIZHPHARM Group operates in the Pharmaceutical Manufacturing industry.

What technology does NIZHPHARM Group use?

Minus sign iconPlus sign icon
NIZHPHARM Group's tech stack includes Facebook PixelAngularJSModernizrYandex MetricaFacebook.

What is NIZHPHARM Group's email format?

Minus sign iconPlus sign icon
NIZHPHARM Group's email format typically follows the pattern of First.Last@stada.ru. Find more NIZHPHARM Group email formats with LeadIQ.

When was NIZHPHARM Group founded?

Minus sign iconPlus sign icon
NIZHPHARM Group was founded in 2008.

NIZHPHARM Group

Pharmaceutical ManufacturingMoskow, Russia1001-5000 Employees

The NIZHPHARM Group (formerly part of the STADA Group) is one of Russia's leading manufacturers of high-quality pharmaceutical products, with a 105-year history.
Our key business areas include:

	•	The over-the-counter (OTC) segment, dietary supplements, and medical devices.
	•	The prescription drug segment, which includes both original medicines and generics.

NIZHPHARM's product portfolio encompasses pharmaceuticals across more than 17 therapeutic areas, with a focus on cardiology, endocrinology, neurology, and men's and women's health (reproductive health).

Our portfolio is a unique combination of localized original socially significant drugs (60%) and products we import into Russia (40%).

The NIZHPHARM Group includes two production sites: Nizhpharm JSC in Nizhny Novgorod and Hemofarm LLC in Obninsk, which enables us to further develop our business with a focus on the local needs of partners and patients in Russia.

Today, NIZHPHARM employs over 2,200 people.

Section iconCompany Overview

Website
stada.ru
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2008
Employees
1001-5000

Section iconMedia & News

Section iconFunding & Financials

  • $10B

    NIZHPHARM Group's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $10B

    NIZHPHARM Group's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.